SCHOTT Pharma Stock Forecast & Price Target
SCHOTT Pharma Price Target 2026
The Quantum Forecast sees a price target of $24.71 (+3.5%) for SCHOTT Pharma in about one month (by Dec 10, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $23.88. Click to see the forecast in the chart.
SCHOTT Pharma Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees SCHOTT Pharma at $23.90 (+0.04%) today around 9:30 AM ET and at $24.01 (+0.49%) today around 2:45 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
SCHOTT Pharma Stock 2026: Price Performance
SCHOTT Pharma stock has gained 34.5% since the start of 2026 and currently trades at $23.88 (as of Nov 11, 2026). Over the same period the SDAX is up 5.7%, putting the stock 28.8 percentage points ahead of the index. Over the past 52 weeks the price ranged between $14.63 and $29.43; it is currently 18.8% below its high of Oct 21, 2026.
SCHOTT Pharma Forecast 2027
Over a horizon of roughly 6 months (until about May 2027), the Quantum Forecast sees a price target of $28.69 for SCHOTT Pharma – +20.1% from today. The range band runs from $20.08 – $37.31: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for SCHOTT Pharma
There are no user forecasts for SCHOTT Pharma yet – be the first to make one.
Make your own forecastAbout SCHOTT Pharma
Schott Pharma makes syringes, vials, cartridges and ampoules for medicines. Based in Mainz, Germany, the company develops and produces primary packaging that comes into direct contact with the drug, including prefillable syringes made of glass and polymer. For sensitive active ingredients such as biologics, vaccines and GLP-1 drugs, high-purity materials and precise manufacturing are essential. Schott Pharma is a subsidiary of Schott AG, which traces its origins to the glass laboratory Otto Schott founded in Jena in 1884; the pharma unit went public in 2023.
Customers are pharmaceutical and biotech companies worldwide that fill injectable medicines. Production takes place at sites in Europe, the Americas and Asia. A strategic focus is on prefillable syringes, which simplify administration for hospitals and patients and carry higher margins than standard vials. Themes for the stock include demand for biologics and GLP-1 drugs, capacity expansion and customer destocking. Majority owner is the Carl Zeiss Foundation via Schott AG. Schott Pharma trades under the ticker 1SXP and is a member of the SDAX.
The current price of SCHOTT Pharma stock is $23.88 (+2.65% vs. the previous close). In today's trading the high was $23.89 and the low $22.98.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about SCHOTT Pharma Stock
What is the SCHOTT Pharma stock forecast?
The Quantum Forecast expects SCHOTT Pharma to reach $24.71 in about one month (by Dec 10, 2026), a change of +3.5% from the current price of $23.88. Over roughly 6 months (by May 2027) the price target is $28.69 (+20.1%).
What is the SCHOTT Pharma stock price target?
Quantum Forecast price targets by time frame: 1 month $24.71 (+3.5%), 2 months $25.05 (+4.9%), 6 months $29.41 (+23.1%), 6 months $28.69 (+20.1%). The range band shows the typical fluctuation around these targets.
Will SCHOTT Pharma stock go up or down?
In the short term the Quantum Forecast points up (+3.5% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for SCHOTT Pharma?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.